Literature DB >> 22153684

Fibrinogen replacement therapy: a critical review of the literature.

Massimo Franchini1, Giuseppe Lippi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 22153684      PMCID： PMC3258985          DOI： 10.2450/2011.0015-11

Source DB:  PubMed          Journal:  Blood Transfus        ISSN： 1723-2007            Impact factor:   3.443


× No keyword cloud information.
  32 in total

1.  A critical evaluation of cryoprecipitate for replacement of fibrinogen.

Authors:  Benny Sørensen; David Bevan
Journal:  Br J Haematol       Date:  2010-04-29       Impact factor: 6.998

2.  Recovery of fibrinogen after administration of fibrinogen concentrate to patients with severe bleeding after cardiopulmonary bypass surgery.

Authors:  C Solomon; U Pichlmaier; H Schoechl; C Hagl; K Raymondos; D Scheinichen; W Koppert; N Rahe-Meyer
Journal:  Br J Anaesth       Date:  2010-03-26       Impact factor: 9.166

3.  Influence of methylene blue photoinactivation treatment on coagulation factors from fresh frozen plasma, cryoprecipitates and cryosupernatants.

Authors:  J A Aznar; S Bonanad; J M Montoro; C Hurtado; A R Cid; M A Soler; A De Miguel
Journal:  Vox Sang       Date:  2000       Impact factor: 2.144

4.  The use of fibrinogen concentrate to correct hypofibrinogenaemia rapidly during obstetric haemorrhage.

Authors:  S F Bell; R Rayment; P W Collins; R E Collis
Journal:  Int J Obstet Anesth       Date:  2010-03-02       Impact factor: 2.603

5.  Pharmacokinetic properties of a pasteurised fibrinogen concentrate.

Authors:  Wolfhart Kreuz; Esther Meili; Kristiina Peter-Salonen; Alena Dobrkovská; Jan Devay; Sabine Haertel; Udo Krzensk; Rudolf Egbring
Journal:  Transfus Apher Sci       Date:  2005-06       Impact factor: 1.764

Review 6.  Fibrinogen and fibrin structure and functions.

Authors:  M W Mosesson
Journal:  J Thromb Haemost       Date:  2005-08       Impact factor: 5.824

7.  Goal-directed coagulation management of major trauma patients using thromboelastometry (ROTEM)-guided administration of fibrinogen concentrate and prothrombin complex concentrate.

Authors:  Herbert Schöchl; Ulrike Nienaber; Georg Hofer; Wolfgang Voelckel; Csilla Jambor; Gisela Scharbert; Sibylle Kozek-Langenecker; Cristina Solomon
Journal:  Crit Care       Date:  2010-04-07       Impact factor: 9.097

Review 8.  Animal model and clinical evidence indicating low thrombogenic potential of fibrinogen concentrate (Haemocomplettan P).

Authors:  Gerhard Dickneite; Ingo Pragst; Christine Joch; Garrett E Bergman
Journal:  Blood Coagul Fibrinolysis       Date:  2009-10       Impact factor: 1.276

9.  Efficacy and tolerability of human fibrinogen concentrate administration to patients with acquired fibrinogen deficiency and active or in high-risk severe bleeding.

Authors:  A Farriols Danés; L Gallur Cuenca; S Rodríguez Bueno; L Mendarte Barrenechea; J Bruno Montoro Ronsano
Journal:  Vox Sang       Date:  2008-01-02       Impact factor: 2.144

Review 10.  Fibrinogen concentrate--a potential universal hemostatic agent.

Authors:  Christian Fenger-Eriksen; Jørgen Ingerslev; Benny Sørensen
Journal:  Expert Opin Biol Ther       Date:  2009-10       Impact factor: 4.388
View more
  38 in total

1.  Emergency and critical care management of acute ischaemic stroke.

Authors:  Stephen A Figueroa; Weidan Zhao; Venkatesh Aiyagari
Journal:  CNS Drugs       Date:  2015-01       Impact factor: 5.749

2.  Fibrinogen concentrate as haemostatic therapy in acquired bleeding disorders: not only a question of dosing strategies and thresholds.

Authors:  Giancarlo M Liumbruno; Stefania Vaglio; Enrico Capuzzo; Massimo Franchini
Journal:  Blood Transfus       Date:  2014-10-23       Impact factor: 3.443

3.  Fibrinogen concentrate in surgery.

Authors:  Giuseppe Marano; Carlo Mengoli; Massimo Franchini; Stefania Vaglio; Sara Gentili; Simonetta Pupella; Giancarlo M Liumbruno
Journal:  Blood Transfus       Date:  2016-03-09       Impact factor: 3.443

4.  Supplementation of fibrinogen concentrate in children with severe acquired hypofibrinogenaemia during chemotherapy for acute lymphoblastic leukaemia: our experience.

Authors:  Paola Giordano; Matteo Luciani; Massimo Grassi; Francesco De Leonardis; Valentina Coletti; Nicola Santoro
Journal:  Blood Transfus       Date:  2013-03-05       Impact factor: 3.443

Review 5.  The use of fibrinogen concentrate for the management of trauma-related bleeding: a systematic review and meta-analysis.

Authors:  Carlo Mengoli; Massimo Franchini; Giuseppe Marano; Simonetta Pupella; Stefania Vaglio; Marco Marietta; Giancarlo M Liumbruno
Journal:  Blood Transfus       Date:  2017-07       Impact factor: 3.443

Review 6.  Is solvent/detergent plasma better than standard fresh-frozen plasma? A systematic review and an expert consensus document.

Authors:  Marco Marietta; Massimo Franchini; M Lucia Bindi; Francesco Picardi; Matteo Ruggeri; Giustina De Silvestro
Journal:  Blood Transfus       Date:  2016-02-17       Impact factor: 3.443

7.  Adhesion of Blood Clots Can Be Enhanced When Copolymerized with a Macromer That Is Crosslinked by Coagulation Factor XIIIa.

Authors:  Karen Y T Chan; Chunyi Zhao; Erika M J Siren; Jeanne C Y Chan; Jeffrey Boschman; Christian J Kastrup
Journal:  Biomacromolecules       Date:  2016-05-17       Impact factor: 6.988

8.  Alternative agents versus prophylactic platelet transfusion for preventing bleeding in patients with thrombocytopenia due to chronic bone marrow failure: a network meta-analysis and systematic review.

Authors:  Michael Desborough; Lise J Estcourt; Anna Chaimani; Carolyn Doree; Sally Hopewell; Marialena Trivella; Andreas V Hadjinicolaou; Paresh Vyas; Simon J Stanworth
Journal:  Cochrane Database Syst Rev       Date:  2016-01-26

9.  Characteristics of thawed pooled cryoprecipitate stored at refrigerated temperature for 24 hours.

Authors:  Esther P Soundar; Meredith Reyes; Laura Korte; Arthur Bracey
Journal:  Blood Transfus       Date:  2017-10-30       Impact factor: 3.443

10.  The effect of fibrinogen concentrate and factor XIII on thromboelastometry in 33% diluted blood with albumin, gelatine, hydroxyethyl starch or saline in vitro.

Authors:  Christoph Johannes Schlimp; Janne Cadamuro; Cristina Solomon; Heinz Redl; Herbert Schöchl
Journal:  Blood Transfus       Date:  2012-12-13       Impact factor: 3.443
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.